The implanted device – currently the smallest implantable medical device in the world – can be used in patients who didn’t respond to medications or other surgeries to slow the progression of glaucoma, according to a Dec. 22 news release from Wilmington Eye.
The iStent Infinite is an adaptation of the iStent, which could only be implanted in patients receiving cataracts surgery, who are typically in their 60s or 70s. The new iStent can be implanted in patients who have been diagnosed with glaucoma, no matter their age.
The surgery was performed by Robert van der Vaart, MD, a board-certified ophthalmic surgeon and glaucoma expert. Dr. van der Vaart will begin seeing new glaucoma patients who are interested in the device.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.